NSE: VAISHALI · PHARMACEUTICALS

Vaishali Pharma Limited Share Price & Company Info

₹7.02-0.71%

End-of-day price, · Educational content, not investment advice

52W low ₹4.7552W high ₹10.48
Market cap
₹86.67 Cras reported by NSE
52-week high
₹10.4831-OCT-2025
52-week low
₹4.7530-MAR-2026
P/E (NSE)
19.56
Face value
₹2.00
Shares issued
13,49,99,995
Volume
17,842₹0.01 Cr traded
Delivery
75.40%of traded quantity
Price band
20%₹5.46 – ₹8.18 on 2026-11-02
Annual volatility
57.51%NSE, from daily returns
Series
EQrolling settlement
ISIN
INE972X01022
Listed on NSE
15-Jan-2020

About Vaishali Pharma Limited

Vaishali Pharma Limited is listed on the National Stock Exchange of India under the symbol VAISHALI in the EQ series. NSE classifies it under the basic industry Pharmaceuticals, part of the Healthcare sector. Its shares were listed on NSE on 15-Jan-2020. Each share has a face value of ₹2.00.

In the end-of-day data for 16 November 2026 the stock closed at ₹7.02, down 0.71% on the day. NSE puts the company's market capitalisation at about ₹86.67 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹4.75 and ₹10.48, so the last price is 47.8% above the low and 33.0% below the high.

17,842 shares changed hands that day, and 75.40% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.

EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.

NSE puts the stock's annualised volatility at 57.51%. That is well above the level of large, established companies, so double-digit swings within a month are common.

Because the share trades below ₹10, it also appears in our list of penny stocks under ₹10, which explains the extra risks that come with low-priced shares.

Vaishali Pharma Limited quarterly results

In the quarter ended June 2026 (un-audited), Vaishali Pharma Limited reported total income of ₹23.47 crore and a net profit of ₹1.49 crore, or ₹0.11 per share. That is a net margin of 6.3% on income.

A year earlier, in the June 2025 quarter, income was ₹24.59 crore with a net profit of ₹1.28 crore. Income has fallen 4.6% year on year. Net profit has risen 16.4%.

Vaishali Pharma Limited was profitable in 5 of the 5 quarters shown below, every one of them. Figures are as filed with NSE, in ₹ crore.

Quarterly results filed with NSE (₹ crore, EPS in ₹)
Quarter endedTotal incomeProfit before taxNet profitEPSStatus
June 202623.471.731.490.11Un-Audited
March 202628.190.180.270.02Audited
December 202525.541.821.300.10Un-Audited
September 202534.291.661.18-0.49Un-Audited
June 202524.591.741.280.10Un-Audited

Vaishali Pharma Limited shareholding pattern

At the end of September 2026, promoters and the promoter group held 31.61% of Vaishali Pharma Limited, with the public holding 68.39%. That is up 5.29 percentage points from 26.32% in June 2025.

Shareholding by category, as filed with NSE each quarter
Quarter endedPromoter & Promoter Group (%)Public (%)
September 202631.6168.39
July 202630.5469.46
June 202631.6168.39
March 202631.6168.39
December 202531.6168.39
December 202531.6168.39
September 202526.3273.68
June 202526.3273.68

Vaishali Pharma Limited share price performance

Over the past year the Vaishali Pharma Limited share price has lost 35.55%, against a fall of 10.92% for the NIFTY 50, so it has underperformed that index by 24.63 percentage points.

Across the 7 periods in the table, the stock beat the NIFTY 50 in 1. Past returns describe what happened; they do not predict what comes next.

Price change by period, as of 2026-11-02 (NSE)
PeriodVAISHALINIFTY 50
1 month-22.28%+1.91%
3 months-11.70%-5.20%
6 months-14.72%-3.94%
1 year-35.55%-10.92%
2 years-64.08%-5.29%
3 years-52.10%+20.44%
5 years+88.66%+30.45%

Vaishali Pharma Limited vs industry peers

NSE compares Vaishali Pharma Limited with 6 other listed companies in Pharmaceuticals. By market capitalisation it ranks 4 of 7.

Its P/E of 19.56 compares with a median of 32.68 for the other companies in the group: the market is paying considerably less for each rupee of its recent earnings.

NSE industry peer comparison, results for JUN 2026 quarter (₹ crore)
CompanyMarket capPrice (₹)P/EPromoter %Qtr incomeQtr net profit
MAKERSL115195.50—0.00——
BALAXI10819.5943.6165.9916.50-1.25
ALPA10750.8024.2157.1929.761.04
VAISHALI87.616.4919.5631.6123.471.49
VILINBIO79.3852.0541.1556.65——
VINEETLAB72.9637.9918.285.9810.501.51
ONYX65.2836.00—0.00——

Vaishali Pharma Limited announcements, board meetings and corporate actions

Latest announcements

The most recent filings Vaishali Pharma Limited has made with NSE, newest first:

  • 17-Oct-2026 · General Updates: Vaishali Pharma Limited has informed the Exchange about General Updates (PDF)
  • 15-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 (PDF)
  • 29-Sep-2026 · Trading Window: Vaishali Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
  • 24-Sep-2026 · Shareholders meeting: Vaishali Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results. (PDF)
  • 24-Sep-2026 · Shareholders meeting: Vaishali Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026 (PDF)
  • 04-Sep-2026 · General Updates: Vaishali Pharma Limited has informed the Exchange about General Updates (PDF)
  • 03-Sep-2026 · Copy of Newspaper Publication: Vaishali Pharma Limited has informed the Exchange about Copy of Newspaper Publication (PDF)
  • 01-Sep-2026 · General Updates: Book Closure for the 19th AGM (PDF)

Board meetings

  • 14-Aug-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
  • 08-Jul-2026 · Fund Raising: To consider Fund Raising
  • 02-Jul-2026 · Fund Raising/Other business matters: To consider Fund Raising and other business matters
  • 30-May-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended March 31, 2026 and other business matters
  • 13-Feb-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended December 31, 2025 and other business matters

Corporate actions

The corporate actions on record include 1 share split, 1 bonus issue. The ex-date is the first day the shares trade without the entitlement.

  • Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share · ex-date 15-Oct-2024 · record date 15-Oct-2024
  • Bonus 1:1 · ex-date 15-Oct-2024 · record date 15-Oct-2024
  • Annual General Meeting · ex-date 19-Sep-2024 · book closure 20-Sep-2024 to 27-Sep-2024
  • Annual General Meeting · ex-date 22-Sep-2023 · book closure 23-Sep-2023 to 29-Sep-2023
  • Extra Ordinary General Meeting · ex-date 27-Dec-2022 · book closure 28-Dec-2022 to 04-Jan-2023
  • Annual General Meeting · ex-date 23-Sep-2022 · book closure 24-Sep-2022 to 30-Sep-2022
  • Annual General Meeting · ex-date 22-Sep-2021 · book closure 24-Sep-2021 to 30-Sep-2021
  • Extra Ordinary General Meeting · ex-date 28-Jul-2021 · book closure 30-Jul-2021 to 05-Aug-2021
  • Annual General Meeting · ex-date 22-Sep-2020 · book closure 24-Sep-2020 to 30-Sep-2020

Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Vaishali Pharma Limited.

Where to find Vaishali Pharma Limited's financials

Direct downloads from NSE:

For full financial statements, shareholding detail and every company announcement, go to the source:

Other Pharmaceuticals stocks on MCX Trends

Frequently asked questions

What is the Vaishali Pharma Limited share price?

Vaishali Pharma Limited (NSE: VAISHALI) closed at ₹7.02 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.

Which sector does Vaishali Pharma Limited belong to?

NSE classifies Vaishali Pharma Limited under Pharmaceuticals, in the Healthcare sector.

What is the 52-week high and low of VAISHALI?

The 52-week high is ₹10.48 (31-OCT-2025) and the 52-week low is ₹4.75 (30-MAR-2026), according to NSE.

Is Vaishali Pharma Limited a penny stock?

At ₹7.02 the share trades below ₹10, so it appears on our list of penny stocks under ₹10. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.

What is the promoter holding in Vaishali Pharma Limited?

Promoters and the promoter group held 31.61% of Vaishali Pharma Limited at the end of September 2026, according to the shareholding pattern filed with NSE.

What were Vaishali Pharma Limited's latest quarterly results?

For the quarter ended June 2026, Vaishali Pharma Limited reported total income of ₹23.47 crore and a net profit of ₹1.49 crore (EPS ₹0.11).

Where can I find Vaishali Pharma Limited's annual report and financial results?

Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for VAISHALI). Screener also lays out several years of financial statements in one place. Links to all of these are above.

More on MCX Trends